Source: British Journal of Ophthalmology. Unidade: FM
Subjects: TRIAGEM, DIABETES MELLITUS, SENSIBILIDADE E ESPECIFICIDADE, CONTRASTE, FATORES DE RISCO
ABNT
PRETI, Rony Carlos et al. Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial. British Journal of Ophthalmology, v. 97, n. 7, p. 885-889, 2013Tradução . . Disponível em: https://doi.org/10.1136/bjophthalmol-2012-302675. Acesso em: 06 nov. 2024.APA
Preti, R. C., Ramirez, L. M. V., Monteiro, M. L. R., Carra, M. K., Pelayes, D. E., & Takahashi, W. Y. (2013). Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial. British Journal of Ophthalmology, 97( 7), 885-889. doi:10.1136/bjophthalmol-2012-302675NLM
Preti RC, Ramirez LMV, Monteiro MLR, Carra MK, Pelayes DE, Takahashi WY. Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial [Internet]. British Journal of Ophthalmology. 2013 ; 97( 7): 885-889.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1136/bjophthalmol-2012-302675Vancouver
Preti RC, Ramirez LMV, Monteiro MLR, Carra MK, Pelayes DE, Takahashi WY. Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial [Internet]. British Journal of Ophthalmology. 2013 ; 97( 7): 885-889.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1136/bjophthalmol-2012-302675